Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Endocrine 15NET 2Other 1Gastrointestinal 1

Conditions

Neuroendocrine Tumors 130Gastro-enteropancreatic neuroendocrine tumor 16Pancreatic Neoplasms 14Neoplasms 12Stomach Neoplasms 8Carcinoma, Neuroendocrine 8Carcinoid Tumor 8Prostatic Neoplasms 7Lung Neoplasms 7Carcinoma, Hepatocellular 7Breast Neoplasms 7Thyroid Neoplasms 6Melanoma 6Esophageal Neoplasms 6Colonic Neoplasms 6Rectal Neoplasms 5Pheochromocytoma 5Neoplasm Metastasis 5Gastrointestinal Stromal Tumors 5Carcinoma 5Adenoma, Islet Cell 5Adenocarcinoma 5Testicular Neoplasms 4Skin Neoplasms 4Serotonin Syndrome 4Sarcoma 4Paraganglioma 4Liver Neoplasms 4Kidney Neoplasms 4Head and Neck Neoplasms 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Acromegaly × NET × Clear all
NCT06253897 2024-12-24

BackSOM

Ipsen

Completed
20 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Acromegaly

NCT01840449 2019-01-14

SOPRANo

Ipsen

Completed
156 enrolled
EndocrineNET

Acromegaly, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡